Preprogen is a privately held, women’s health company with the first-and-only, non-invasive, at-home gynecologic cancer cell collection screening kit, PadKit™. Preprogen aims to empower women at risk for endometrial cancer and other health issues and their physicians by giving them peace of mind knowing that Preprogen products provide a fast and non-invasive modern approach to cancer cell screening.
There is currently no standard or routine screening test to detect endometrial cancer. Preprogen’s PadKit is designed to detect endometrial cancer and other gynecologic cancers, known cancer biomarkers (e.g., BRCA1, BRCA2), vaginal infections, infectious diseases, including STDs, fetal conditions, and other women’s health issues to empower women’s health prescribed by and under the comprehensive care of a physician.
“Our goal is to reduce deaths from endometrial cancer…
it’s as simple as that.”
— Dr. Shalom Hirschman, Chief Scientific Officer & Medical Director and
Eli Goldberger, Founder & Chief Executive Officer
Preprogen’s novel cell science technology is proven to collect whole, intact cells from a woman’s gynecologic tract in the comfort of her home for fast lab screening.
Empower women’s health through early gynecologic cancer screening
To provide women and their doctors with a trusted, at-home screening tool to detect gynecologic cancers and other health issues early when treatment may be curative.
“We are on a mission to stop cancer from killing the people we love.”
— Eli Goldberger, Founder & Chief Executive Officer
“Preprogen’s cell science technology brings a much-needed innovation to detecting gynecologic cancers and protecting
women’s health.”
— Margaret Blaetz, Chief Compliance Officer
Chief Scientific Officer & Medical Director
Dr. Shalom Z. Hirschman is the Chief Scientific Officer and Medical Director of Preprogen. He invented PadKit’s novel cell science technology and unique Interlabial Collection Pad™ (ICP).
Dr. Hirschman served for over 30 years as the Director of Infectious Diseases and Vice Chairman of the Department of Medicine at Mount Sinai School of Medicine and Medical Center where he was among the first to recognize HIV/AIDS.
Dr. Hirschman has been a member of many distinguished professional bodies including the American Society for Microbiology, the Biophysical Society, the American Association for the Advancement of Science, the American Society for the Study of Liver Diseases, the American Federation for Clinical Research, The Harvey Society, American College of Physicians, American Society for Infectious Diseases, and the American Medical Association. He served as Vice Chairman of the Microbiology Section, NY Academy of Sciences and then as Chairman.
Dr. Hirschman was elected to membership and fellowship in the American College of Physicians, the Infectious Diseases Society of America, the Royal Society of Tropical Medicine and Hygiene, the American Society for Clinical Investigation, the Association of American Physicians, the Society for Experimental Biology and Medicine, the American College of Clinical Pharmacology, and the Molecular Medicine Society.
Founder & CEO
Eli Goldberger is the Founder and Chief Executive Officer of Preprogen.
Mr. Goldberger is a successful entrepreneur, focusing on advancing innovations in pharmaceuticals, women’s health, and energy, and he currently serves on the Board of Directors of Universal Energy Corp.
In the past, Mr. Goldberger served as Founder & CEO of Payday Solutions, a regional payroll and human capital management company.
Chief Compliance Officer
Margaret E. Blaetz is the Chief Compliance Officer at Preprogen.
For decades, Ms. Blaetz has worked closely with physicians in test and specimen collection techniques. She is an experienced clinical laboratory scientist; Physician Office Laboratory (POL) manager; research and development expert as well as experienced in laboratory sales.
In 2014, Ms. Blaetz earned a certification for CLIA Compliance, retaining this certification through annual continuing education and also obtaining a certification as a Clinical Laboratory Consultant, CLC (AMT). She maintains an open dialogue with the New Jersey State Department of Health and CLIA surveyors to ensure information is up to date and accurate for all regulations.
In 2015, Margaret expanded her focus to include technical consultation, opening her own company, East Coast Clinical Consultants, LLC, which used her training and compliance program to assist POL’s outside of her employer’s organization.
Over the years, Ms. Blaetz has expanded her business, speaking on behalf of multiple organizations at the national level and writing for COLA, the American Academy of Family Practice and Laboratory Manager Magazine. She is skilled in information technology having customized and implemented a Laboratory Information System (LIS) in a hospital laboratory.
